ESR1 and breast carcinoma: This study of MCF-7 and SKBR-3 breast cancer, which reflects the patients with ER+ and HER2+ breast cancer, respectively, and may contribute and provide new insights into new therapeutics that are about to influence both the biochemical and biomechanical responses of cancer cells.